TLR5 and inflammatory bowel disease: Although human monogenic TLR5 deficiency is rare and not yet well characterized clinically, the strong mechanistic evidence from animal and translational studies justifies its inclusion among innate immune defects with potential relevance to IBD-like and metabolic phenotypes [130].